Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-dermatophyte onychomycosis.

Aditya K Gupta1, Jennifer E Ryder, Robert Baran

  • 1Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Science Center (Sunnybrook site), Toronto, Canada. agupta@execulink.com

Dermatologic Clinics
|May 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Onychomycosis in Diabetics: A Common Infection with Potentially Serious Complications.

Life (Basel, Switzerland)·2025
Same author

Artificial Intelligence and Large Language Models in the Fight Against Superficial Fungal Infections: Friend or Foe?

Clinical, cosmetic and investigational dermatology·2025
Same author

Understanding the evolving treatment landscape of hidradenitis suppurativa: An analysis of All of Us.

PloS one·2025
Same author

Onychomycosis in special populations.

Future microbiology·2025
Same author

Management and Genetics of Alopecia Areata within the USA: A Cross-Sectional Study of All of Us.

Skin appendage disorders·2025
Same author

A Canadian Algorithm on the Management of Telogen Effluvium.

Journal of cutaneous medicine and surgery·2025
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Non-dermatophyte molds are increasingly found in nail fungus (onychomycosis), possibly due to better diagnostics. While treatments exist, some patients may not fully recover from these infections.

Area of Science:

  • Mycology
  • Dermatology
  • Infectious Diseases

Background:

  • Non-dermatophyte organisms are increasingly identified as causes of onychomycosis.
  • This rise may be linked to enhanced diagnostic methods and greater recognition of these fungi as pathogens.
  • The growing population of immunocompromised individuals necessitates careful evaluation of all isolated organisms.

Purpose of the Study:

  • To highlight the increasing prevalence of non-dermatophyte molds in onychomycosis.
  • To emphasize the importance of considering all fungal isolates as potential pathogens.
  • To discuss treatment responses in non-dermatophyte mold onychomycosis.

Main Methods:

  • Review of current literature on onychomycosis and non-dermatophyte fungal infections.

Related Experiment Videos

  • Analysis of diagnostic trends and awareness of fungal etiologic agents.
  • Evaluation of clinical outcomes for patients with non-dermatophyte mold onychomycosis.

    • Main Results:

    • Non-dermatophyte organisms are a growing cause of onychomycosis.
    • Improved diagnostics and awareness contribute to the apparent increase.
    • Some patients may experience poor or incomplete response to antifungal therapies.

    Conclusions:

    • Non-dermatophyte molds are significant pathogens in onychomycosis.
    • Vigilant mycological diagnosis is crucial, especially in immunocompromised patients.
    • Treatment outcomes for non-dermatophyte mold onychomycosis can be variable.